Meloxican: Influence on arachidonic acid metabolism Part II. In vivo findings

Biochemical Pharmacology

Volumn 51, Issue 1, 1996, Pages 29-38

  Engelhardt, G ^a   Bogel R ^a   Schnitzler, Chr ^a   Utzmann, R ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

In vivo; Leucotrienes; Meloxicam; Prostaglandins; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; DICLOFENAC; DIPYRONE; FLURBIPROFEN; INDOMETACIN; LEUKOTRIENE B4; LEUKOTRIENE C4; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROSTAGLANDIN E2; TENIDAP; TENOXICAM; THROMBOXANE B2;

ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD LEVEL; BRAIN; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; EXUDATE; INFLAMMATION; KIDNEY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONITIS; PLEURISY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; STOMACH; TISSUE LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; BRAIN; CONVULSANTS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEMALE; GASTRIC JUICE; INFLAMMATION; ISOENZYMES; KIDNEY; LEUKOTRIENE B4; MALE; MICE; PENTYLENETETRAZOLE; PLEURISY; RATS; STOMACH; THIAZINES; THIAZOLES;

EID: 0030061289     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02110-8     Document Type: Article

References (48)

1. Engelhardt G, Homma D, Schlegel K, Schnitzler Chr and Utzmann R, Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new nonsteroidal anti-inflammatory agent. Inflamm Res 44: 423-433, 1995.
2. Engelhardt G, Meloxicam, a potent inhibitor of adjuvant arthritis in the rat. Scand J Rheumatol 98: (Suppl) Abstr. No. 110, 1994.
3. Vane JR, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232-235, 1971.
4. Vane JR, Mode of action of aspirin and similar compounds. In: Prostaglandin Synthetase Inhibitors (Eds. Robinson HJ and Vane JR), pp. 155-163. Raven Press, New York, 1974.
5. Raz A, Wyche A and Needleman P, Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci USA 86: 1657-1661, 1989.
6. Xie W, Chipman JG, Robertson DL, Erikson RC and Simmons DL, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by RNA splicing. Proc Natl Acad Sci USA 88: 2692-2696, 1991.
7. Moncada S, Grygliewski R, Bunting S and Vane JR, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
8. Mitchell JA, Akarasereenont P, Thiemerman C, Flower R and Vane JR, Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11693-11697, 1994.
9. Vane J, Towards a better aspirin. Nature 367: 215-216, 1994.
10. Meade EA, Smith WL and DeWitt DL, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614, 1993.
11. Lanza FL, A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 24: 24-31, 1989.
12. Garcia Rodriguez LA and Jick H, Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769-772, 1994.
13. Vinegar R, Tonax JF and Selph JL, Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc Soc Exp Biol Med 143: 711-714, 1973.
14. Shay H, Komarov SA, Fels SS, Meranze D and Gruenstein MA. Simple method for the uniform production of gastriculceration in the rat. Gastroenterology 5: 45-61, 1945.
15. Linder A, Statistische Methoden. 4th ed. pp. 148-162, Birkhäuser, Basel, 1964.
16. Fieller EC, A fundamental formula in the statistics of biological assay, and some applications. Q J Pharm Pharmacol 17: 117-125, 1944.
17. Steinhauer HB and Hertting G, Lowering of the convulsive threshold by nonsteroidal anti-inflammatory drugs. Eur J Pharmacol 69: 199-205, 1981.
18. Fu JY, Masferrer JL, Seibert K, Raz A and Needleman P, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265: 16737-16740, 1990.
19. Kujubu DA and Herschman HR, Dexamethasone inhibits mitogen induction of the TIS 10 prostaglandin synthase cyclooxygenase gene. J Biol Chem 267: 7991-7994, 1992.
20. Masferrer JL, Seibert K, Zweifel B and Needleman P, Endogenous glucocorticoids regulate inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89: 3917-3921, 1992.
21. Masferrer JL, Zweifel BS, Seibert K and Needleman P, Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Incest 86: 1375-1379, 1990.
22. Sebaldt RJ, Shelter JR, Oates JA, Roberts LJ and Fitzgerald GA, Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci USA 87: 6974-6978, 1990.
23. Vane JR, The induction of a second and different cyclooxygenase is important in inflammation. In: William Harvey Res Conf, Sept. 28-29, London 1992, Vol. 3, Abstr. p. 3.
24. Vane JR and Botting RM, New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44: 1-10, 1995.
25. Harada Y, Hatanaka K, Kawamura M, Majima M, Takahara M, Saito M, Ono T and Katori M, Possible involvement of inducible cyclooxygenase (COX) in carrageenin-induced pleurisy. In: World Congress Inflammation '93, IAIS, Vienna, October 10-15, 1993, Abstr. p. 153.
26. Weissmann G, The eicosanoids of asthma. N Engl J Med 308: 454-455, 1983.
27. Blackburn WD, Heck LW, Loose LD, Eskra JD and Carty TJ, Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arthritis Rheum 34: 204-210, 1991.
28. Kimmey MB, NSAIDs, ulcers and prostaglandins. J Rheumatol 19, Suppl 36, 68-73, 1992.
29. Wynne HA and Rawlins MD, Are systemic levels of non steroidal anti-inflammatory drugs relevant to acute upper gastrointestinal haemorrhage? Eur J Clin Pharmacol 44: 309-313, 1993.
30. Whittle BJR and Vane JR, A biochemical basis for the gastrointestinal toxicity of nonsteroidal anti-rheumatoid drugs. Arch Toxicol Suppl. 7, 315-322, 1984.
31. Graham DY, Agraval NM and Roth SH, Prevention of NSAID-induced gastric ulcer with synthetic prostaglandin, misoprostol: multicentre double-blind placebo controlled trial. Lancet 2: 1277-1280, 1988.
32. Szabo S, Mechanisms of gastric mucosal injury and protection. J Clin Gastroenterol 13: S21-S24, 1991.
33. Whittle BJR, Higgs GA, Eakins KE, Moncada S and Vane JR, Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271-273, 1980.
34. Green JR, Böttcher I and Peskar BA, Effect of a new anti-inflammatory compound, CGP 28237, on arachidonate metabolism in rat gastrointestinal tissue. Agents Actions 23: 110-111, 1988.
35. Lee DKH, Cohen R, Gilliar J, Mulder B and Smith T, A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat. Agents Actions 19: 228-232, 1986.
36. Lee D and Dvornik D, Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats. Life Sci 36: 1157-1162, 1985.
37. Rosenkranz B, Fischer C, Meese CO and Frölich JC, Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. Br J Clin Pharmacol 21: 309-317, 1986.
38. Sraer J, Ardaillon N, Sraer JD and Ardaillon R, In vitro prostaglandin synthesis by human glomeruli and papillae. Prostaglandins 23: 855-864, 1982.
39. 2α, excretion by nonsteroidal anti-inflammatory drugs in rats. Biochem Pharmacol 32: 1347-1352, 1983.
40. Bippi H and Frölich JC, Effects of acetylsalicyclic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol 29: 305-310, 1990.
41. Lang B, Hank P, Meske S, Keller E and Peter HH, Die Nierenfunktion unter Therapie mit nichtsteroidalen Antiphlogistika. Z Rheumatol 50: 366-370, 1991.
42. Malandrino S, Angelini M, Baldini L, Barenghi L, Borsa M, Carraba M and Cariotti GC, Effects of ibuprofen on renal function in patients with rheumatoid arthritis. In: 2nd World Conference on Inflammation, Monte Carlo, March 19-22, 1986, A144 (Ed. Bettelli A), Bioscience Edipruit, Geneva.
43. Prescott LF, Mattison P, Menzies DG and Manson LM, The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers. Br J Clin Pharmacol 29: 403-412, 1990.
44. Clive DM and Stoff JS, Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med 310: 563-572, 1984.
45. Dunn MJ, Nonsteroidal anti-inflammatory drugs and renal function. Ann Rev Med 35: 411-428, 1984.
46. Seyberth HW, Die Bedeutung der renalen Prostaglandine für die Nierenfunktion im frühen Kindesalter. Monatsschr Kinderheilk 135: 178-184, 1987.
47. Sörgel F, Krankau J, Lang E, Braun J and Gessier U, The effects of indomethacin, ketoprofcn and piroxicam on basal and furosemide-induced sodium excretion in the healthy subject. In: Side Effects of Anti-inflammatory Drugs (Eds. Rainsford KD and Velo GP), MTP Press Ltd, Lancaster, 1985.
48. Yamagata K, Andreasson KJ, Kaufmann WE, Barnes CA and Worley PF, Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386, 1993.